Sun Pharmaceutical Peer Comparison

NSE: SUNPHARMA | BSE: 524715

₹1,777.70

₹16.70 (0.95%)

As on 30-Oct-2026IST

Market cap

₹4,26,662 Cr

Revenue (TTM)

₹61,631 Cr

P/E Ratio

38.9

P/B Ratio

4.8

Div. Yield

0.9 %

Edit

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Market cap (₹ Cr)	4,26,662	1,76,306	1,11,489	1,12,699	1,02,797
Revenue (₹ Cr)	61,631	17,400	28,139	33,097	15,379
Net Profit (₹ Cr)	11,037.19	2,099.00	2,868.29	2,759.70	2,249.69
Net Margin (%)	17.23	12.10	9.94	8.03	14.32
RoE (%)	14.23	16.47	8.90	7.30	13.86
Price to Earnings	38.91	83.01	38.48	40.25	45.84
Price-To-Book	4.78	9.60	3.15	2.90	5.85

Income Statement (₹ Cr)

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Operating Revenue	61,630.92	17,400.00	28,138.89	33,097.40	15,378.58
Total Income	64,063.12	17,348.00	28,855.45	34,352.50	15,705.47
Total Expenditure	43,720.59	11,626.00	23,306.78	28,236.90	11,301.83
EBITDA	17,910.33	5,774.00	4,832.11	4,860.50	4,076.75
Depreciation	3,004.86	1,916.00	1,352.39	2,141.40	907.11
EBIT	14,905.47	3,858.00	3,479.72	2,719.10	3,169.64
Interest	338.59	886.00	60.93	450.40	513.87
Other Income	2,432.20	-52.00	716.56	1,255.10	326.89
Exceptional Items	-1,962.40	-107.00	-275.91	0.00	-129.75
Profit before Tax	15,036.68	2,813.00	3,859.44	3,523.80	2,852.91
Provision for Tax	3,999.49	714.00	991.15	764.10	603.22
Profit after Tax	11,037.19	2,099.00	2,868.29	2,759.70	2,249.69

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Shareholder's Funds	89,279.88	18,373.00	35,395.50	38,807.00	17,582.22
Minority Interest	-20.97	25.00	43.21	40.20	-20.87
Non-Current Liabilities	1,683.12	18,258.00	935.18	3,074.90	5,214.33
Current Liabilities	23,591.58	7,984.00	6,976.93	15,430.30	5,884.79
Total Liabilities	1,08,407.20	43,613.69	42,342.71	56,576.70	27,754.83

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Non-Current Assets	44,135.45	33,165.00	16,372.16	26,891.10	20,096.89
Current Assets	69,266.58	10,517.00	25,060.80	29,732.20	7,956.27
Total Assets	1,08,407.20	43,613.69	42,342.71	56,576.70	27,754.83
Total Debt*	4,081.61	14,798.24	257.97	7,734.10	6,021.78
Net Current Assets	45,675.00	2,533.00	18,083.87	14,301.90	2,071.48
Contingent Liabilities	1,587.05	379.25	987.37	336.14	924.77

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Cash From Operating Activities	12,419.18	3,022.71	3,940.02	5,673.70	3,121.29
Cash Flow from Investing Activities	-11,344.05	-12,712.41	-2,326.13	-6,549.30	-196.42
Cash from Financing Activities	-2,512.55	10,150.60	-1,233.65	829.00	-2,952.69
Net Cash Inflow / Outflow	-1,437.42	460.90	380.24	-46.60	-27.82

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
ROCE (%)	19.11	19.27	16.00	13.75	13.24
ROE (%)	14.23	16.47	8.90	7.30	13.86
ROA (%)	10.10	6.98	6.86	4.93	7.79
EBIT Margin (%)	24.19	22.17	12.37	8.22	20.61
Net Margin (%)	17.23	12.10	9.94	8.03	14.32
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Revenue Growth (%)	12.13	42.06	-0.74	-3.53	13.53
EBIT Growth (%)	7.78	21.02	-42.59	-58.47	31.59
Net Profit Growth (%)	4.94	-1.92	-47.41	-51.77	27.79
EPS Growth (%)	6.57	-1.09	-42.93	-51.50	34.22
Book Value Growth (%)	15.72	10.51	10.59	12.99	13.74

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Price / Earnings	34.69	73.16	35.89	40.25	43.76
Price / Book Value	4.78	9.60	3.15	2.90	5.85
Dividend Yield (%)	0.90	0.82	0.94	0.59	0.04
EV/EBITDA	22.23	32.75	21.27	23.33	26.20
Market Cap (₹ Cr)	4,21,639.92	1,42,851.87	98,797.18	1,04,763.81	82,801.75

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Debt to Equity	0.00	0.63	0.00	0.00	0.17
Short term debt to equity ratio	0.05	0.35	0.00	0.16	0.04
Current Ratio	2.94	1.32	3.59	1.93	1.35
Quick Ratio	2.40	0.92	2.62	1.40	0.95
Interest Coverage	45.41	4.17	64.34	8.82	6.55

	Sun Pharmaceutical	Torrent Pharma	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Debtors to sales (%)	28.89	19.53	21.32	30.64	14.17
Asset Turnover	0.56	0.58	0.67	0.59	0.53
Receivable days	89.14	45.41	52.05	103.79	39.93
Inventory Days	67.85	52.67	57.25	79.94	51.78
Payable days	213.72	244.06	115.96	84.78	111.46
Cash Conversion Cycle	-56.72	-145.98	-6.65	98.95	-19.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.